METHANEX CORPORATION (MEOH): what the price assumes
In the published model solve dated 2026-Q2, anchored at $51.88, METHANEX CORPORATION (MEOH) is priced for +1.1% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-24.
Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/MEOH
Headline
| Field | Value |
|---|---|
| Ticker | MEOH |
| Company | METHANEX CORPORATION |
| Sector / Industry | Basic Materials |
| Current price | $51.88/sh |
| Composition | China 14% / Europe 26% / United States 20% / South America 14% / South Korea 12% / Other Asia 9% / Canada 5% |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Operating margin (value-band context) | 3.2% |
| Operating margin today | 12.0% |
| Margin compression (value-band) | -8.8pp |
| Implied growth | 1.1% |
| Multiple paid | 16x operating income |
The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.
Solve inputs: computed at a 7.8% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.8pp.
Reconcile: at the x-ray's 9.3% required return this reads ~10.4%/yr; the models below use their own rates.
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | -0.27σ |
| cohort percentile (of 77 peers) | 40 |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by earnings-power and relative-multiple and growth-DCF value, while asset-based lands below the price. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 2.56x | 5 | expensive |
| Earnings | 0.98x | 3 | justifies |
| Relative | 0.75x | 3 | justifies |
| Growth | 0.61x | 3 | justifies |
Families that justify the price: Earnings, Relative, Growth Families that call it expensive: Asset
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $119.81 | 0.43x | yes | FCF base $0.9B, growth -5% (input: historical growth), terminal g 0.5%, WACC 9.3%, 5yr projection |
| DCF Exit Multiple | Growth | $85.52 | 0.61x | yes | Exit EV/EBITDA: 4.0x / 4.1x / 6.1x (bear / base = today's held flat / bull), 5yr |
| Relative Valuation | Relative | $58.07 | 0.89x | yes | P/E 18.11x (blended: static sector reference 14x + trailing (TTM) 28x), scenarios: 15.4x / 18.1x / 20.8x (bear / base = reference held flat / bull), EV/EBITDA 8x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $20.24 | 2.56x | yes | BV/sh $35.26, ROE (TTM) 5.3%, ke 9.3% |
| Two-Stage Excess Return | Asset | $14.55 | 3.57x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $27.99 | 1.85x | yes | Rev $3.6B, growth -5% (input: historical growth; tapered), Terminal P/S: 1.0x / 1.1x / 1.3x (bear / base = today's held flat / bull, cap 8x) |
| Growth-Adjusted P/E | Relative | — | — | no | — |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | $52.89 | 0.98x | yes | Normalized EBIT (5y avg op income, one-time charges added back) $0.48B × (1−29%) / WACC 9.3% → EPV (no growth) |
| Residual Income | Asset | $13.87 | 3.74x | yes | BV $35.26 + 5yr PV of (ROE (TTM) 5.3% − Kₑ 9.3%) × BV; BV grows 3.5%/yr |
| Graham Number | Asset | $29.54 | 1.76x | yes | √(22.5 × EPS $1.10 × BVPS $35.26) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | $96.22 | 0.54x | yes | EBITDA $0.88B × sector EV/EBITDA 8.0x |
| FCF Yield | Earnings | $133.62 | 0.39x | yes | FCF $916.6M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | $0.92 | 56.39x | yes | EPS $1.10 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median) |
| ROIC-Justified P/B | Asset | $50.86 | 1.02x | yes | BV $35.26 × (ROIC 13.3% / WACC 9.3%) |
| P/Sales Sector | Relative | $69.61 | 0.75x | yes | Revenue $3.59B × sector P/S 1.5x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | $11.89 | 4.36x | yes | EPS $1.10 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $2.3b |
| Net debt / NOPAT (after-tax) | 7.58x |
| Net debt / operating income (pre-tax) | 5.40x |
| Interest coverage | 2.0x |
| Share count CAGR (buyback) | -1.2% |
| Burning cash | no |
Bullet Takeaways
- Methanex sells one commodity into a market that abruptly lost a large slice of its supply, and the effect landed in price: the company realized $351 a tonne in the first quarter of 2026 and pointed to roughly $500 to $525 a tonne for April and May.
- The counterweight is a balance sheet carrying about $3.1 billion of net debt against $2.7 billion of shareholders' equity at the end of March 2026, which is why management put debt repayment ahead of buybacks.
- Gas supply rather than demand is the operating constraint to watch, and the nearest dated test is second-quarter results on July 28, 2026.
Bull Case
One molecule, for most of its history. Methanex makes methanol, ships it, and is paid the difference between what methanol sells for and what the natural gas to make it costs. For most of the last decade that sounded like a reason to stay away. This year it is the reason to look.
What changed is supply, not demand. On the April call management said Middle East producers ship roughly 20 million tonnes of methanol a year into the global market, and that this volume has been sharply reduced since March following the conflict that escalated in late February. Inventories drew down worldwide. Prices followed.
The arithmetic from there is unusually direct. Methanex realized an average $351 a tonne in the first quarter; for April and May the company pointed to roughly $500 to $525 a tonne, with prices outside China running higher still at $550 to $650. Volume, meanwhile, is close to fixed: full-year guidance is 9.0 million tonnes of equity methanol production plus 0.3 million tonnes of ammonia. A producer whose output is set and whose selling price is not becomes a levered bet on that price, and the selling price moved by nearly half in a single quarter.
So the first quarter reads as a floor rather than a picture. At $351 a tonne Methanex still produced $220 million of adjusted earnings before interest, taxes, depreciation and amortization, alongside a reported net loss of $14 million. Management then said it expects significantly stronger earnings and cash flows in the second quarter. Nothing in that requires a forecast. It requires April and May to have been what the company said they were.
The second leg is the asset base itself. Methanex closed its purchase of OCI Global's international methanol business in June 2025, adding methanol and ammonia capacity at Beaumont, Texas and a half interest in Natgasoline. Beaumont turned out 85,000 tonnes of ammonia in the first quarter, a second product line the old Methanex did not have. The $30 million cost-synergy plan is running on schedule, though the company carries a heavier fixed-cost base through 2026 and expects the full benefit only from January 2027.
Capital allocation follows the same logic, and management has been unusually specific about the order. Roughly $290 million of the term loan is set to be repaid in the second quarter; after that the priority moves to redeeming the bonds maturing in 2027, with share repurchases considered only where the value is obvious. In a levered producer at a strong point in its cycle, every dollar of cash flow that retires a bond moves value from lenders to shareholders. Doing it in that sequence is the unglamorous version of the bull case, and it is the version that still works if methanol falls back.
The obvious objection is that all of this rests on an outage that could end. Management's answer is that it does not expect quick normalization and believes the disruption runs for some time. That is a judgment, not a fact. The fact is that the company entered the disruption holding the largest position in the product and left the quarter with $379 million of cash and access to a $600 million revolving facility. Being the biggest seller of something that suddenly got scarce is not a strategy. It is a good place to be standing.
Bear Case
Supply shocks end. That is the sentence the bull case has to survive, and it is not a rhetorical flourish: what Methanex realizes per tonne is set by how much methanol the world can make, and the volume that left the market this spring can come back. Middle East producers ship roughly 20 million tonnes a year under normal conditions. When that returns, the same fixed cost base that magnifies profit on the way up magnifies the shortfall on the way down. A single-commodity producer does not get to keep only the good half of the cycle.
What turns that ordinary observation into a valuation problem is the multiple already attached to it. At $56.49 the shares carry about 17.3 times the operating income of the trailing year, a level that sits at the very top of the chemical peer distribution, well beyond its upper quartile. The price also assumes operating-income growth near 4.4% a year from that same base, struck before any of the spring move reached the income statement. Neither number is extreme alone. Together they say the market has already decided the disruption is durable and has repriced the base accordingly, which leaves very little for the case where it is not.
The book-value arithmetic makes the point from another angle. The price sits about 2.6 times where book value plus profitability lands, because the return Methanex earned on its equity over the trailing year did not clear what an equity holder needs to be paid. Against $2.7 billion of shareholders' equity and roughly $3.1 billion of net debt, that shortfall is not academic.
Gas is the constraint that does not respond to price. Methanex needs cheap natural gas delivered to plants it cannot relocate, and two of its positions are visibly strained. In New Zealand, management said that if OMV ceases production from the Maui field by the end of the year, Methanex would no longer be capable of running its plant there. In Chile, one plant idles from mid-quarter through the southern winter. Egypt ran at full rates in the first quarter, which is welcome and is not a guarantee. A methanol plant without gas is a set of pipes.
Then there is the debt. Trailing operating income covered the interest bill about 2.0 times over, which is thin for a business whose top line is a commodity quote. The acquired Beaumont and Natgasoline assets bring a $30 million synergy plan that is not expected to be fully realized until January 2027, so 2026 carries the heavier costs while the benefit sits in the following year. If methanol normalizes before the repayment schedule is finished, the sequence management laid out simply takes longer, and equity holders are last in that queue.
None of this makes the coming quarter anything other than good. It will be good. The bear case is not about the next print. It is about what is being paid today for the prints after that one, against a base the market has not seen yet and a supply situation nobody at Methanex controls.
Valuation
Methanol has one price, and Methanex's income statement is largely that price against a volume the company has already committed to producing. That makes the question of what the market is paying unusually clean. At $56.49 on July 24, 2026, the shares carry about 17.3 times the operating income earned over the trailing year.
The price assumes operating-income growth of roughly 4.4% a year from here, a pace the company has delivered and exceeded within its own record. The demanding part is not the rate. It is the denominator. The trailing year that multiple is struck against closed before Middle East supply left the market, at realized prices near $351 a tonne rather than the $500 to $525 the company guided to for April and May. Whether 17 times is dear or cheap depends entirely on which of those two worlds the next several years resemble. Operating margins ran near 12% across the trailing period.
The methods used to triangulate a business like this disagree in an unusual direction. Earnings power lands essentially on top of today's price; peer multiples and the discounted cash-flow methods both land above it. Only the asset lens dissents, and it dissents hard: the price sits about 2.6 times where book value plus profitability lands. That lens marks the company against the return it earned on its equity over the last twelve months, which is precisely the wrong twelve months for a producer whose selling price bottomed and then jumped by half. A cyclical measured at its trough looks expensive on book-value arithmetic, and that says more about the measuring window than about the plants.
Balance sheet is where the caution belongs. Methanex closed March 2026 with $379 million of cash, access to a $600 million revolving facility, and about $3.1 billion of net debt against $2.7 billion of equity. Trailing operating income covered the interest bill about 2.0 times over, which is adequate rather than comfortable when the revenue line is a commodity quote. Management's stated plan is to repay roughly $290 million of the term loan in the second quarter and then redeem the 2027 maturities. Lenders are paid before shareholders, and management has been clear that the next two quarters of cash flow belong to them.
Catalysts
The nearest dated event is second-quarter results on July 28, 2026, with the call the following morning. That print is the first time the spring price move reaches the income statement in full, and management has already described the input: realized prices of roughly $500 to $525 a tonne for April and May against $351 in the first quarter, and an expectation of significantly stronger earnings and cash flows.
Two operating items sit inside the same quarter and cut the other way. One Chilean plant idles from mid-quarter through the southern winter, and New Zealand volumes were already easing. The New Zealand position is the one with a deadline attached: management said that if OMV stops producing from the Maui gas field by year end, Methanex would no longer be capable of running its plant there. Full-year equity production guidance of 9.0 million tonnes of methanol and 0.3 million tonnes of ammonia is what would have to move.
On the balance sheet, roughly $290 million of term-loan repayment is scheduled inside the second quarter, after which management said attention turns to the 2027 maturities and, only where the value is obvious, to repurchases. The cost synergies from the Beaumont and Natgasoline acquisition total $30 million and are not expected to land in full until January 2027, which leaves 2026 carrying the heavier fixed-cost base.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- CBT (Cabot Corporation)
- FY2025 10-K: …of any of these customers, or a significant reduction in volumes sold to them, could have a material adverse effect on the segment until such business is replaced. Under appropriate circumstances, we have entered into supply arrangements with certain customers, the typical duration of which is one year. These…
- FY2025 10-K: …economic characteristics and if the operating segments are similar in the following areas: i) nature of products and services; ii) nature of production processes; iii) type or class of customer for their products and services; iv) methods used to distribute the products or provide services; and v) if applicable, the…
- FUL (FULLER H B CO)
- FY2025 10-K: …Adhesives operating segment, and combining our Insulated Glass, Woodworking and Composite businesses, previously part of the Engineering Adhesives operating segment, with Construction Adhesives Roofing and Building Envelope and Infrastructure businesses to form the Building Adhesive Solutions operating segment. All…
- FY2025 10-K: …our financial results. We experience substantial competition in each of the operating segments and geographic areas in which we operate. Our wide variety of products are sold in numerous markets, each of which is competitive. Our competitive position in markets is, in part, subject to external factors. For example,…
- REYN (REYNOLDS CONSUMER PRODUCTS INC.)
- FY2025 10-K: …for a significant portion of our revenue. In 2025, sales to our top ten customers accounted for 74% of our total revenue. Three customers each accounted for sales greater than 10% of our total net revenue in 2025. Customers A, B and C accounted for 31%, 17% and 11%, respectively, of our total revenue. Customer A and…
- FY2025 10-K: …of competition from new entrants to our markets as well as from existing competitors, including competitors outside the United States who may have lower production costs. Our customers continuously evaluate their suppliers, often resulting in downward pricing pressure and increased pressure to continuously introduce…
- SMG (Scotts Miracle-Gro Co)
- FY2025 10-K: …• lower material costs in our U.S. Consumer segment; • lower sales volume in our Hawthorne segment; and • a decrease in impairment, restructuring and other charges; • partially offset by higher sales volume in our U.S. Consumer segment; • inventory write-down charges included within "volume, mix and other" associated…
- FY2025 10-K: …share. Our projections may not accurately predict the volume impact of price increases, which could adversely affect our business, financial condition and results of operations. Because of the concentration of our sales to a small number of retail customers, the loss of one or more of, or a significant reduction in…
- SLVM (SYLVAMO CORPORATION)
- FY2025 10-K: …margins. Our industry-leading brands, known for their long-standing reputation in their respective markets for product quality and performance, allow us to maintain our long-term relationships with top-tier customers throughout economic cycles. Our international reach and strong positioning across retail, merchant…
- FY2025 10-K: …resources and scale than ours, which could adversely impact our competitive position. Further, actual or speculated consolidation among competitors, or the acquisition by, or of, our third party service providers and business partners by competitors could increase the competitive pressures faced by us as customers…
- AVNT (AVIENT CORPORATION)
- FY2025 10-K: …No customer accounted for more than 3% of our consolidated revenues in 2025. Research and Development One of our strategic drivers is to "Amplify Innovation," and we have substantial technology and development capabilities, powered by approximately 1,100 employees serving in technical capacities, approximately 120 of…
- FY2025 10-K: …progress implementing our new strategy. Our growth vector sales are outpacing the rest of the Company, with defense and healthcare leading the way. Internal R&D collaboration has increased, resulting in technology sharing across businesses and geographies. We have bolstered digital capabilities with a focus on pilot…
- FMC (FMC CORPORATION)
- FY2025 10-K: …service provider costs, of $14.5 million and severance and employee separation costs of $1.8 million in connection with Project Foundation. • Revenue of $3,467.4 million in 2025 decreased $778.7 million or approximately 18 percent versus last year primarily driven by one-time commercial actions taken to position the…
- FY2025 10-K: …31, 2024 due to a significant decline in volumes during the first quarter as a result of continued pressure from channel destocking behavior. Volume recovery as a result of improved inventory levels in the channel during the following quarters partially offset the decrease in the first quarter. Unfavorable pricing…
- TROX (TRONOX HOLDINGS PLC)
- FY2025 10-K: …of raw materials, utilities, transportation and similar costs rise, our operating expenses will increase and could adversely affect our business, especially if we are unable to pass price increases relating to raw materials, utilities, transportation and similar costs through to our customers. The markets for many of…
- FY2025 10-K: …needs, including through the capital markets and for the purpose of financing planned capital expenditures and results of operations. Our industry and the end-use markets in which we compete are highly competitive and are characterized by excessive production capacity, particularly in China. Competition and excess…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Methanex Q1 2026 results release and earnings call, April 30, 2026 · Methanex Q1 2026 results release and balance sheet · Methanex investor relations calendar · Methanex Q1 2026 earnings call, April 30, 2026 · Methanex Q1 2026 results release